Fluciclovine PET/CT in Multiple Myeloma Patients
Recruiting
Observational Study
Myeloma, Multiple
PET-CT
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10 (estimated)
- Sponsor
- Oslo University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Comparison between image findings at aminoacid PET/CT and FDG PET/CT for myeloma patients
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Multiple myeloma patients suitable for ASCT treatment
Exclusion Criteria:
* Patients with contraindications to ASCT treatment
Contacts